[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632761":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":34,"responsibleParty":52,"collaborators":54,"id":57,"slug":18,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":18,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Amazentis SA","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Cosmetic routine","EXPERIMENTAL","The \"cosmetic routine\" arm will apply the skin care product",[13],"Other: Skin care product",{"label":15,"type":16,"description":17,"interventionNames":18},"Untreated control","NO_INTERVENTION","The \"Untreated control\" arm will not apply the skin care product",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"OTHER","Skin care product","The cosmetic skin care product will be applied twice daily to half of the face",[9],[26,31],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Brad Currier, PhD","CONTACT","+41215521274","bcurrier@timeline.com",{"name":32,"role":28,"phone":18,"phoneExt":18,"email":33},"Anurag Singh, MD, PhD","asingh@amazentis.com",[35],{"facility":36,"status":37,"city":38,"state":18,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"SGS proderm GmbH","RECRUITING","Schenefeld","22869","Germany",{"type":42,"coordinates":43},"Point",[44,45],9.48146,54.04644,{"lat":45,"lon":44},[48],{"name":49,"role":28,"phone":50,"phoneExt":18,"email":51},"Dr. rer. nat. Katrin Unbereit","+49 40 83935899","HSinnecker@proderm.de",{"type":53,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[55],{"name":36,"class":56},"UNKNOWN","100632761",false,"NCT07517887","Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure","Anti-aging Efficacy Study on One Cosmetic Product vs Untreated","HCP-S1","INCLUSION CRITERIA\n\n* Written Informed Consent to participate in the study\n* Written Informed Consent for the use of the images for marketing purposes applies to subgroup participants of study 26.0112.\n* Willingness to actively participate in the study and to come to the scheduled visits\n* Female\n* Male, approximately 10 to 15% with little facial hair\n* From 45 to 65 years of age\n* Healthy skin in the test areas\n* Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score)\n\nExclusion criteria\n\n* Female participants: Pregnancy or lactation\n* Drug addicts, alcoholics\n* AIDS, HIV-positive or infectious hepatitis\n* Conditions which exclude a participation or might influence the test reaction\u002Fevaluation\n* Participation or being in the waiting period after participation in cosmetic and\u002For pharmaceutical studies pertaining to the test area\n* Active skin disease at the test area\n* Documented allergies to face\u002Feye care products or their ingredients\n* Diabetes mellitus\n* Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and\u002For hormonal treatment within the last 2 years\n* One of the following illnesses with reduced physical capability\u002Ffitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases\n* Epilepsy\n* Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation\n* Regular use of tanning beds within the last 6 weeks prior to the start of the study\n* Any topical medication at the test area within the last 3 days prior to the start of the study\n* Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and\u002For antihistamines (e.g. antiallergics) within the last 7 days prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study\n* Therapy with antibiotics within the last 2 weeks prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study\n* Cosmetic surgery procedure in the test area (e.g. laser, facelift) within the last 2 years and throughout the entire course of the study\n* Cosmetic surgery treatments in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and throughout the entire course of the study\n* Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study and throughout the entire course of the study",true,"ALL","45 Years","65 Years",{"count":69,"type":70},30,"ESTIMATED","INTERVENTIONAL",[73],"NA","The aim of this study is to investigate the impact of a topical product on skin health and aging",[76,77],"Aging","Wrinkle Appearance","2026-04-24",{"date":80,"type":81},"2026-04-29","ACTUAL",{"date":83,"type":81},"2026-04-22",{"date":85,"type":70},"2026-10-15",{"name":5,"class":6},1]